Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,590 recalls, newest first

Class II · Moderate risk

Papav 300/Phent 5mg/10mL

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1094-2018
Class II · Moderate risk

P/P/P 0.02/40/2mg/mL

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1093-2018
Class II · Moderate risk

PRO/PA/PH/AT 18mcg/1.8mg/

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1092-2018
Class II · Moderate risk

PRASH 12.2mcg/1.22m/19.29

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1091-2018
Class II · Moderate risk

Vitamin D3 Injection

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1087-2018
Class II · Moderate risk

Dehydrated Alcohol Solution

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1086-2018
Class II · Moderate risk

Morphine Sulf inhalation

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1085-2018
Class II · Moderate risk

DMSO 6.25% Opth Sol

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1081-2018
Class II · Moderate risk

Atropine 0.01% Opth Solution

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1080-2018
Class II · Moderate risk

10 mg/mL Rocuronium Bromide

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1045-2018
Class II · Moderate risk

5 mg/mL Ephedrine Sulfate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1044-2018
Class II · Moderate risk

10 mcg/mL Fentanyl Citrate

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Terminated cGMP deviation PharMEDium Services, LLC D-1043-2018

Recalls by year